Amelia S. Aitken

518 total citations
7 papers, 410 citations indexed

About

Amelia S. Aitken is a scholar working on Genetics, Oncology and Biotechnology. According to data from OpenAlex, Amelia S. Aitken has authored 7 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Oncology and 2 papers in Biotechnology. Recurrent topics in Amelia S. Aitken's work include Virus-based gene therapy research (6 papers), CAR-T cell therapy research (4 papers) and Cancer Research and Treatments (2 papers). Amelia S. Aitken is often cited by papers focused on Virus-based gene therapy research (6 papers), CAR-T cell therapy research (4 papers) and Cancer Research and Treatments (2 papers). Amelia S. Aitken collaborates with scholars based in Canada and France. Amelia S. Aitken's co-authors include Marie‐Claude Bourgeois‐Daigneault, Dominic G. Roy, John C. Bell, Adrian Pelin, Jean‐Simon Diallo, Theresa Falls, Nikolas T. Martin, David F. Stojdl, Brian D. Lichty and Guy Ungerechts and has published in prestigious journals such as Nature Communications, Scientific Reports and Science Translational Medicine.

In The Last Decade

Amelia S. Aitken

7 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amelia S. Aitken Canada	7	295	245	146	130	54	7	410
Weizhou Hou United States	9	315 1.1×	278 1.1×	168 1.2×	144 1.1×	61 1.1×	13	453
Joshua D. Freedman United Kingdom	6	314 1.1×	249 1.0×	167 1.1×	114 0.9×	66 1.2×	7	402
Dongling Gao China	8	257 0.9×	232 0.9×	147 1.0×	113 0.9×	78 1.4×	22	401
Jiankai Liang China	13	204 0.7×	259 1.1×	201 1.4×	84 0.6×	47 0.9×	25	386
Shohei Miyamoto Japan	10	191 0.6×	257 1.0×	163 1.1×	100 0.8×	48 0.9×	16	392
Megha Shettigar United States	3	355 1.2×	325 1.3×	174 1.2×	196 1.5×	72 1.3×	3	533
Jana de Sostoa Spain	7	291 1.0×	204 0.8×	157 1.1×	82 0.6×	41 0.8×	9	360
Laetitia Fend France	10	305 1.0×	250 1.0×	127 0.9×	222 1.7×	62 1.1×	18	455
Sarah Knocke Germany	8	341 1.2×	256 1.0×	146 1.0×	210 1.6×	67 1.2×	8	488
Ibrahim Ragab Eissa Japan	8	190 0.6×	198 0.8×	123 0.8×	69 0.5×	57 1.1×	12	307

Countries citing papers authored by Amelia S. Aitken

Since Specialization

Citations

This map shows the geographic impact of Amelia S. Aitken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amelia S. Aitken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amelia S. Aitken more than expected).

Fields of papers citing papers by Amelia S. Aitken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amelia S. Aitken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amelia S. Aitken. The network helps show where Amelia S. Aitken may publish in the future.

Co-authorship network of co-authors of Amelia S. Aitken

This figure shows the co-authorship network connecting the top 25 collaborators of Amelia S. Aitken. A scholar is included among the top collaborators of Amelia S. Aitken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amelia S. Aitken. Amelia S. Aitken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Roy, Dominic G., Monique Marguerie, S. Khan, et al.. (2021). Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination. Nature Communications. 12(1). 2626–2626. 51 indexed citations

2.

Bourgeois‐Daigneault, Marie‐Claude, Dominic G. Roy, Amelia S. Aitken, et al.. (2018). Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy. Science Translational Medicine. 10(422). 233 indexed citations

3.

Bastin, Donald, Amelia S. Aitken, Adrian Pelin, et al.. (2018). Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference. Journal for ImmunoTherapy of Cancer. 6(1). 62–62. 7 indexed citations

4.

Aitken, Amelia S., Dominic G. Roy, Nikolas T. Martin, et al.. (2017). Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice. Journal of Immunotherapy. 41(3). 125–129. 14 indexed citations

5.

Aitken, Amelia S., Dominic G. Roy, & Marie‐Claude Bourgeois‐Daigneault. (2017). Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies. Biomedicines. 5(1). 3–3. 26 indexed citations

6.

Rogers, Stephanie R., et al.. (2016). Ku70 Serine 155 mediates Aurora B inhibition and activation of the DNA damage response. Scientific Reports. 6(1). 37194–37194. 16 indexed citations

7.

Bourgeois‐Daigneault, Marie‐Claude, Dominic G. Roy, Adrian Pelin, et al.. (2016). Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment. Breast Cancer Research. 18(1). 83–83. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact